Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis by Emilie Glavind (3159438)

“…</p><p>Results</p><p>The FHNC was markedly decreased in the alcoholic hepatitis patients compared with the healthy controls (7.2±4.9 L/h vs. 37.4±6.8 L/h, P<0.01), and the largest decrease was observed in those with severe alcoholic hepatitis (4.9±3.6 L/h vs. 9.9±4.9 L/h, P<0.05). …”

Loss of MMP7 leads to a decrease in transformation in cells lacking PKP3. by Srikanta Basu (721886)

HCV infection decreases L1 retrotransposition frequency. by Anja Schöbel (10668438)

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

Homozygous deletion of <i>ERG251</i> leads to the decreased ergosterol accumulation in the absence of FLC and decreased production of toxic dienol in the presence of FLC. by Xin Zhou (54275)

hESCs-CM inhibited cell cycle progression of cancer cells and initiated a pro-apoptotic program. by Shufeng Zhou (398572)

Product characteristics of 0.1% FLU ophthalmic suspensions used in this study. by Tokio Obata (10783047)

6a-P peptide decreases VEGF binding activity to cell surface by immunocytochemistry. by Tong-Young Lee (250877)

“…<p>Immunocytochemistry was used to confirm the FACS results. VEGF (0.1 µg/ml) binding intensity on HUVECS is decreased when the peptide (1 µg/ml) or VEGF-Trap (0.1 µg/ml) are present (A) (Bar, 20 µm). …”

Decreased STOC frequency and amplitude in CASMCs of <i>db/db</i> mice. A by Angélica Rueda (105891)

A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

Decreased health-related quality of life in angiodysplasia patients: A cross-sectional cohort by Karina V. Grooteman (4050388)

ZfpA overexpression decreases voriconazole efficacy <i>in vitro</i> and during infection. by Taylor J. Schoen (15383519)

Iguratimod decreased production of BAFF, IL-6, IL-17A and IL-21. by Qingran Yan (637573)

Memantine decreases the level of activated GSK-3β and the expression of intraneuronal Aβ. by Xiaochuan Wang (550306)

“…<p>A) While the level of total GSK-3β was not changed, pSer-9 GSK-3β was markedly decreased in AAV1-I₁^PP2A as compared with the AAV1-GFP rats in hippocampus, cerebral cortex and ventricular areas. …”

Antagomir-208a and atorvastatin decreases myocardial fibrosis induced by aorta-caval shunt. by Bao-Wei Wang (505054)

<i>csrnp1a</i> knockdown decreases the number of blood cells in circulation. by Jaime Espina (106906)

“…(H) Chart summarizing the morpholino dose-phenotype quantifications of 26 hpf control embryos (n = 71) and injected with 2,5 ng (n = 69), 5 ng (n = 85) or 10 ng (n = 87) of Mocsrnp1a spt morpholino. (I) qPCR with primers located in exon 2 and 3 of 24 hpf control embryos (C) and splicing morphants injected with two concentrations, 2,5 and 5 ng per embryo, showing the relative expression of <i>csrnp1a</i> message, which decreases significantly in a dose-dependent manner (t student p<0,01).…”

Screening of AJ01 T3SS Inhibitors. by Fa Dai (15810913)

JAM-A and junctional proteins' expression was decreased at the invading tumor edge in vivo and in vitro. by Masato Murakami (217507)

“…Quantification is reported at the right panel, data are means +/− SEM of 3 experiments performed in quadruplicates. **p<0.01 by unpaired Student-t test. Scale bar; 300 µm; D) Western blot analysis of JAM-A and ZO-1 expression in 4T1 cells in sparse, sub-confluent, and confluent conditions. …”

Cumulative sensitivity and specificity of the microfluidic assay for influenza A for decreasing specimen viral loads. by Qingqing Cao (113950)

Dcp1a protein levels are decreased by KapB expression and Torin treatment. by Carolyn-Ann Robinson (13297009)